Total Payments
$73,931
2024 Payments
$22,226
Companies
14
Transactions
113
Payment Breakdown by Category
Consulting$47,890 (64.8%)
Research$12,578 (17.0%)
Travel$6,675 (9.0%)
Other$3,580 (4.8%)
Food & Beverage$2,733 (3.7%)
Education$462.15 (0.6%)
Gifts$11.94 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $47,890 | 11 | 64.8% |
| Unspecified | $12,578 | 15 | 17.0% |
| Travel and Lodging | $6,675 | 26 | 9.0% |
| Food and Beverage | $2,733 | 45 | 3.7% |
| Honoraria | $2,500 | 1 | 3.4% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $1,080 | 1 | 1.5% |
| Education | $462.15 | 10 | 0.6% |
| Gift | $11.94 | 4 | 0.0% |
Payments by Type
General
$61,352
98 transactions
Research
$12,578
15 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| PFIZER INC. | $14,730 | 16 | $0 (2024) |
| Shire North American Group Inc | $13,060 | 28 | $0 (2018) |
| Bayer HealthCare Pharmaceuticals Inc. | $12,165 | 21 | $0 (2019) |
| Novo Nordisk Inc | $8,806 | 5 | $0 (2018) |
| HEMA Biologics, LLC | $8,509 | 17 | $0 (2024) |
| GENZYME CORPORATION | $7,541 | 10 | $0 (2024) |
| Bio Products Laboratory, Inc. | $3,559 | 3 | $0 (2017) |
| BIOVERATIV THERAPEUTICS INC. | $2,238 | 3 | $0 (2018) |
| Takeda Pharmaceuticals U.S.A., Inc. | $2,100 | 1 | $0 (2022) |
| Octapharma USA, Inc. | $511.20 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $22,226 | 25 | PFIZER INC. ($8,810) |
| 2023 | $5,810 | 10 | PFIZER INC. ($5,790) |
| 2022 | $2,343 | 3 | Takeda Pharmaceuticals U.S.A., Inc. ($2,100) |
| 2021 | $2,670 | 10 | HEMA Biologics, LLC ($2,520) |
| 2019 | $6,452 | 13 | Bayer HealthCare Pharmaceuticals Inc. ($6,392) |
| 2018 | $17,236 | 20 | Novo Nordisk Inc ($8,806) |
| 2017 | $17,193 | 32 | Shire North American Group Inc ($7,106) |
All Payment Transactions
113 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/19/2024 | PFIZER INC. | BENEFIX (Biological), BEQVEZ | — | In-kind items and services | $1,400.00 | Research |
| Study: BENEFIX CLINICAL PUBLICATION PROGRAM • Category: HEMATOLOGY | ||||||
| 10/12/2024 | HEMA Biologics, LLC | SevenFact (Biological) | Consulting Fee | Cash or cash equivalent | $4,900.00 | General |
| Category: Hematology | ||||||
| 10/12/2024 | HEMA Biologics, LLC | SevenFact (Biological) | Travel and Lodging | Cash or cash equivalent | $291.56 | General |
| Category: Hematology | ||||||
| 10/12/2024 | HEMA Biologics, LLC | SevenFact (Biological) | Food and Beverage | In-kind items and services | $78.73 | General |
| Category: Hematology | ||||||
| 10/12/2024 | HEMA Biologics, LLC | SevenFact (Biological) | Food and Beverage | In-kind items and services | $73.64 | General |
| Category: Hematology | ||||||
| 10/12/2024 | HEMA Biologics, LLC | SevenFact (Biological) | Food and Beverage | In-kind items and services | $72.21 | General |
| Category: Hematology | ||||||
| 10/12/2024 | HEMA Biologics, LLC | SevenFact (Biological) | Food and Beverage | In-kind items and services | $19.00 | General |
| Category: Hematology | ||||||
| 10/12/2024 | HEMA Biologics, LLC | SevenFact (Biological) | Travel and Lodging | Cash or cash equivalent | $6.82 | General |
| Category: Hematology | ||||||
| 10/11/2024 | HEMA Biologics, LLC | SevenFact (Biological) | Food and Beverage | In-kind items and services | $18.19 | General |
| Category: Hematology | ||||||
| 10/01/2024 | PFIZER INC. | — | Consulting Fee | Cash or cash equivalent | $2,000.00 | General |
| 09/24/2024 | HEMA Biologics, LLC | SevenFact (Biological) | Travel and Lodging | Cash or cash equivalent | $317.31 | General |
| Category: Hematology | ||||||
| 09/23/2024 | HEMA Biologics, LLC | SevenFact (Biological) | Travel and Lodging | Cash or cash equivalent | $211.44 | General |
| Category: Hematology | ||||||
| 08/29/2024 | PFIZER INC. | BENEFIX (Biological), BEQVEZ | — | In-kind items and services | $3,200.00 | Research |
| Study: BENEFIX CLINICAL PUBLICATION PROGRAM • Category: HEMATOLOGY | ||||||
| 06/27/2024 | PFIZER INC. | BENEFIX (Biological), BEQVEZ | — | In-kind items and services | $330.00 | Research |
| Study: BENEFIX CLINICAL PUBLICATION PROGRAM • Category: HEMATOLOGY | ||||||
| 03/27/2024 | PFIZER INC. | BENEFIX (Biological), BEQVEZ | — | In-kind items and services | $940.00 | Research |
| Study: BENEFIX CLINICAL PUBLICATION PROGRAM • Category: HEMATOLOGY | ||||||
| 03/01/2024 | GENZYME CORPORATION | — | Consulting Fee | Cash or cash equivalent | $6,016.00 | General |
| 03/01/2024 | GENZYME CORPORATION | — | Travel and Lodging | In-kind items and services | $501.80 | General |
| 03/01/2024 | GENZYME CORPORATION | — | Travel and Lodging | In-kind items and services | $286.07 | General |
| 03/01/2024 | GENZYME CORPORATION | — | Travel and Lodging | In-kind items and services | $263.35 | General |
| 03/01/2024 | GENZYME CORPORATION | — | Food and Beverage | In-kind items and services | $140.00 | General |
| 03/01/2024 | GENZYME CORPORATION | — | Food and Beverage | In-kind items and services | $70.00 | General |
| 03/01/2024 | GENZYME CORPORATION | — | Food and Beverage | In-kind items and services | $50.00 | General |
| 03/01/2024 | GENZYME CORPORATION | — | Food and Beverage | In-kind items and services | $50.00 | General |
| 03/01/2024 | GENZYME CORPORATION | — | Food and Beverage | In-kind items and services | $50.00 | General |
| 02/07/2024 | PFIZER INC. | XYNTHA (Biological), BENEFIX | — | In-kind items and services | $940.00 | Research |
| Study: PF05230907 PF05280602 GIROCTOCOGENE FITELPARVOVEC FIDANACOGENE ELAPARVOVEC MARSTACIMAB MOROCTOCOG ALFA MULTI PRODUCT NONACOG ALFA CLINICAL PUBLICATION PROGRAM • Category: HEMATOLOGY | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| BENEFIX CLINICAL PUBLICATION PROGRAM | PFIZER INC. | $5,870 | 4 |
| Natural History Study of Factor IX Treatment and Complications (B-Natural) | BIOVERATIV THERAPEUTICS INC. | $2,238 | 3 |
| PF05280602 CLINICAL PUBLICATION PROGRAM | PFIZER INC. | $1,600 | 3 |
| NONACOG ALFA PF05280602 PF05230907 MOROCTOCOG ALFA MULTI PRODUCT FIDANACOGENE ELAPARVOVEC GIROCTOCOGENE FITELPARVOVEC MARSTACIMAB CLINICAL PUBLICATION PROGRAM | PFIZER INC. | $940.00 | 1 |
| PF05230907 PF05280602 GIROCTOCOGENE FITELPARVOVEC FIDANACOGENE ELAPARVOVEC MARSTACIMAB MOROCTOCOG ALFA MULTI PRODUCT NONACOG ALFA CLINICAL PUBLICATION PROGRAM | PFIZER INC. | $940.00 | 1 |
| NONACOG ALFA CLINICAL PUBLICATION PROGRAM | PFIZER INC. | $660.00 | 2 |
| FIDANACOGENE ELAPARVOVEC CLINICAL PUBLICATION PROGRAM | PFIZER INC. | $330.00 | 1 |
About Dr. Suchitra Acharya, MD
Dr. Suchitra Acharya, MD is a Hematology & Oncology healthcare provider based in New York, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/16/2006. The National Provider Identifier (NPI) number assigned to this provider is 1871683052.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Suchitra Acharya, MD has received a total of $73,931 in payments from pharmaceutical and medical device companies, with $22,226 received in 2024. These payments were reported across 113 transactions from 14 companies. The most common payment nature is "Consulting Fee" ($47,890).
Ad
Practice Information
- Specialty Hematology & Oncology
- Other Specialties Pediatrics, Pediatric Hematology-Oncology
- Location New York, NY
- Active Since 10/16/2006
- Last Updated 09/11/2025
- Taxonomy Code 207RH0003X
- Entity Type Individual
- NPI Number 1871683052
Products in Payments
- ADVATE (Biological) $9,206
- SevenFact (Biological) $8,509
- BENEFIX (Biological) $7,470
- Jivi (Drug) $6,392
- Coagadex (Biological) $3,559
- NO PRODUCT DISCUSSED (Drug) $2,238
- XYNTHA (Biological) $940.00
- WILATE (Biological) $511.20
- Gammaplex (Drug) $221.15
- HEMLIBRA (Biological) $149.85
- Afstyla (Biological) $77.52
- Kcentra (Biological) $20.00
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Hematology & Oncology Doctors in New York
Jeffrey Zwicker, M.d, M.D
Hematology & Oncology — Payments: $1.2M
Hematology & Oncology $1.2M
Manuel Hidalgo Medina, M.d, M.D
Hematology & Oncology — Payments: $1.1M
Hematology & Oncology $1.1M
Dr. Ahmed Sawas, M.d, M.D
Hematology & Oncology — Payments: $807,524
Hematology & Oncology $807,524
Ruben Niesvizky, Md, MD
Hematology & Oncology — Payments: $734,512
Hematology & Oncology $734,512
Jeffrey Laurence, Md, MD
Hematology & Oncology — Payments: $706,018
Hematology & Oncology $706,018
Dr. Joshua Sabari, M.d, M.D
Hematology & Oncology — Payments: $603,205
Hematology & Oncology $603,205